Higher SOAT1 expression has been demonstrated in GBM compared to astrocytoma of lower malignancy (CNS WHO grades 2–3), with absence of expression in pilocytic astrocytoma, CNS WHO grade 1, and control brains with cortical dysplasia [3]. This evidence concerns the gene SOAT1 and astrocytoma (excluding glioblastoma).